Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Type I Hypersensitivity
Interventions
BIOLOGICAL

Tree MATA MPL or Tree MATA

"4 injections of increasing dose strength for Tree MATA MPL or Tree MATA:~1. 600 SU/0.5 ml~2. 1600 SU/0.5 ml~3. 4000 SU/0.5 ml~4. 4000 SU/0.6 ml~4 injections of 0.5 mL of 2% w/v L-tyrosine for Placebo"

Trial Locations (1)

L4W 1N2

Allied Research International Inc., Mississauga

Sponsors
All Listed Sponsors
lead

Allergy Therapeutics

INDUSTRY